Walter M. Gregory

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

G. Morgan, W. Gregory, M. Drayson, 2012, Haematologica.

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

G. Morgan, W. Gregory, M. Drayson, 2012, Blood.

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

K. Maclennan, W. Gregory, P. Hoskin, 2001, Blood.

Article Title: A compendium of myeloma associated chromosomal copy number abnormalities and their prognostic value Short Title: SNP-based genome mapping in myeloma

M. Jenner, Z. Konn, L. Chiecchio, 2010 .

Maintenance Thalidomide May Improve Progression Free but Not Overall Survival; Results from the Myeloma IX Maintenance Randomisation

G. Morgan, W. Gregory, M. Drayson, 2008 .